PLMNF yields 1360.54% · JNJ yields 2.14%● Live data
📍 PLMNF pulled ahead of the other in Year 1
Combined, PLMNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PLMNF + JNJ for your $10,000?
Palamina Corp., through its subsidiary, Palamina S.A. de C.V., focuses on the exploration of mineral deposits in Mexico, Canada, and Peru. It explores for gold, copper, and silver deposits. The company owns 100% interests in the Usicayos Gold project covering an area of 14,600 hectares, the Bendi Gold project covering an area of 13,400 hectares, the Cori Gold project covering an area of 18,000 hectares, and the Inca Gold project covering an area of 2,600 hectares that are located in south-eastern Peru. It also owns 100% interests in the Tinka iron oxide copper-gold project covering an area of 1,800 hectares located in southern Peru; the Galena Silver Copper project covering an area of 10,300 hectares located at south-eastern Peru; and the El Santuario property located in the Cardonal district, Hidalgo State, Mexico. The company was incorporated in 2015 and is headquartered in Toronto, Canada.
Full PLMNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.